ISA Workshop – Amyloidosis from Bench to Bedside and Back Again

Il Collegio Fondazione Ghislieri
October 13-14, 2025

The International Society of Amyloidosis (ISA) will organize this year’s ISA Workshop “Amyloidosis from Bench to Bedside and Back Again” at the “Collegio Fondazione Ghislieri” in Pavia, Italy, on October 13 and 14, 2025.

This focused workshop will bring together leading experts, researchers, and clinicians in the field of amyloidosis to discuss cutting-edge advancements in diagnostics, treatment response assessment, screening approaches, and drug development.

The workshop will explore novel approaches to assessing treatment response in AL and ATTR amyloidosis, focusing on measurable residual disease (MRD), advanced imaging techniques, biomarkers, and patient-reported outcomes to enhance clinical decision-making. Additionally, it will highlight advancements in screening and early diagnosis, examining genetic predisposition, artificial intelligence applications, and novel biomarkers to improve early detection and patient outcomes.

A key focus will be on drug development and therapeutic innovations, particularly AI-driven drug repurposing, targeted therapies, and emerging research models, aiming to accelerate the development of effective treatments. The event will also emphasize global collaboration and registry initiatives, addressing international standards for research and the importance of cross-border sample sharing to foster innovation and improve amyloidosis management worldwide.